Impaired H-2 expression in B16 melanoma variants

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Histocompatibility antigen (H-2b) expression is crucial for immune recognition and rejection of tumor cells.
• B16 melanoma is a widely used model for studying tumor immunology and metastasis.
• In vitro culture conditions can influence the immunophenotype of cancer cell lines.

Purpose of the Study:

• To investigate the expression of H-2b alloantigens in different B16 melanoma cell lines cultured in vitro.
• To assess how in vitro culture affects the immunogenicity and cytotoxic sensitivity of B16 melanoma cells.
• To correlate changes in H-2 antigen expression with the metastatic potential of B16 melanoma cells.

Main Methods:

• In vivo tumor growth assays in syngeneic and allogeneic mice.
• In vitro cell-mediated cytotoxicity assays using anti-H-2b immune lymphocytes.
• Serological analysis via absorption of anti-H-2b antisera activity to detect H-2b alloantigens.

Main Results:

• B16-F1 cells showed no detectable H-2b alloantigens and resisted lysis by anti-H-2b effectors.
• Newly derived B16-A and B16-B lines initially expressed H-2b antigens but lost sensitivity to cytotoxic effectors and H-2Kb expression after in vitro passages, with reduced H-2Db expression.
• These H-2 altered cell lines demonstrated an increased capacity to kill allogeneic hosts in vitro.

Conclusions:

• In vitro culture of B16 melanoma lines leads to significant alterations in H-2b alloantigen expression.
• Loss of H-2 antigen expression correlates with decreased sensitivity to immune-mediated cytotoxicity and increased ability to target allogeneic hosts.
• Altered H-2 expression in B16 melanoma cells may play a role in modulating their metastatic behavior.